Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study
GOSH
3 other identifiers
interventional
50
1 country
2
Brief Summary
Title: Investigation of neutrophil defects associated with periodontal disease and tooth loss in children. A clinical study. Objectives: The primary objective of this study is:
- To investigate presence of periodontal disease and response to periodontal treatment in children affected by neutrophil defects The secondary objectives of this study are:
- To investigate presence of other dental diseases in children affected by neutrophil defects
- To assess oral microbiological and inflammatory parameters in children affected by neutrophil defects Primary outcomes: The primary outcomes are (a) presence of periodontal disease as assessed by clinical factors: probing pocket depth, attachment level, bleeding on probing and radiographic bone loss) (b) microbiological and host response factors: detected in periodontal pockets and gingival crevicular fluid and (c) response to treatment Study sample: Children affected by neutrophil defects and meeting outlined inclusion and exclusion criteria Number of participants: 50 children Study design: This is a longitudinal treatment study. All participants will attend for 4-7 visits during the study as outlined below:
- Screening visit (visit 1): consent procedure, dental examination, saliva and plaque sampling
- Baseline visit (visit 2):, detailed periodontal examination, dental radiographs, sampling of gingival crevicular fluid and, if appropriate scaling, polishing and oral hygiene instructions
- Non-surgical periodontal treatment (visit 3A to 3D, max 4 sessions): oral hygiene instructions and supra- and sub-gingival debridement (under local anaesthesia if necessary)
- Follow-up Visit (visit 4, 4th to 7th visit) (six months following treatment): detailed dental examination, oral hygiene instructions, sampling of saliva, subgingival plaque and gingival crevicular fluid, tooth scaling and polishing.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2016
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 17, 2017
CompletedFirst Posted
Study publicly available on registry
March 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2019
CompletedNovember 14, 2022
December 1, 2016
2 years
January 17, 2017
November 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Probing pocket depth
Measurement periodontal pocket depth at baseline (in millimetres, mm)
At baseline only (0 months)
Attachment level
Measurement of attachment level at baseline (in millimetres, mm)
At baseline only (0 months)
Bleeding on probing
Proportion of bleeding sites on probing at baseline (in percentage, %)
At baseline only (0 months)
Radiographic bone loss
Proportion of bone loss in relation to total root length at baseline. (in percentage, %)
At baseline only (0 months)
Microbiological assay
Microbiological analysis with next generation sequencing of the 16s rRNA metagenome at baseline. (Proportion of specified microbes present in sample at baseline)
At baseline only (0 months)
GCF
Gingival crevicular fluid inflammatory markers (Proportion specified inflammatory markers present in sample at baseline)
At baseline only (0 months)
Secondary Outcomes (5)
Response to treatment: Probing pocket depth
From baseline (0 months) to follow-up (24 months)
Response to treatment: Attachment level
From baseline (0 months) to follow-up (24 months)
Response to treatment: Bleeding on probing
From baseline (0 months) to follow-up (24 months)
Response to treatment: Microbiological assay
From baseline (0 months) to follow-up (24 months)
Response to treatment: GCF
From baseline (0 months) to follow-up (24 months)
Study Arms (1)
Non surgical Periodontal therapy
EXPERIMENTALAll children will be offered an oral hygiene and tooth scaling and polishing session. For children affected by periodontal disease, subgingival debridement will also be performed according to needs, with the aim to disrupt the subgingival biofilm responsible for the onset and progression of the periodontal pathology. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. In addition, when required, nitrous oxide sedation (NOS) could be used before treatment. Caries will be treated as necessary (shared care with the general dental practitioners / community dental services). Children with mucosal lesions requiring treatment will be given a letter for their GDP suggesting referral to a collaborating expert in Oral Medicine (Prof. Stephen Porter).
Interventions
For children affected by periodontal disease, oral hygiene advice, non surgical periodontal treatment will also be performed according to needs. This can be accompanied, when appropriate, by the use of local anaesthesia and adjunctive antimicrobials (systemic or locally applied subgingivally), according to the clinical presentation and the child's medical conditions. Accurate supra- and sub-gingival removal of calculus and dental plaque will be performed both with ultrasonic and/or manual instruments. The necessary sub-gingival debridement will be performed in 1 to 4 visits (either full mouth treatment, half-mouth treatment or quadrant-wise treatment) depending on patient preference and practical considerations, using manual (Gracey curettes, Hu-Friedy) and ultrasonic devices (EMS). .
Eligibility Criteria
You may qualify if:
- Age 4-16 years
- Diagnosis of one of the following neutrophil defects (as confirmed by the treating physician):
- Disorders of neutrophil numbers
- Cyclic neutropenia
- Congenital neutropenia
- Severe Congenital Neutropoenia
- X-linked Neutropoenia
- Disorders of neutrophil function
- Leucocyte Adhesion Defect s
- Other neutrophil disorders/ undefined neutrophil disorders (functional defects demonstrated on testing but genetic basis not yet known)
- Combined immunodeficiency syndromes
- Wiskott Aldrich Syndrome
- Hyper IgM Syndrome
- Chediak Higashi Syndrome
- Undefined combined immunodeficiency (functional defects demonstrated on testing but genetic basis not yet known)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Center for Oral Clinical Research, Queen Mary, University of London
London, Greater London, E1 2AD, United Kingdom
Dental and Maxillofacial Department, Great Ormond Street Hospital for Children
London, WC1N 3JH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luigi Nibali, PhD
Queen Mary University of London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2017
First Posted
March 3, 2017
Study Start
December 1, 2016
Primary Completion
December 1, 2018
Study Completion
December 1, 2019
Last Updated
November 14, 2022
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share